PubMed Health⌕ Search

Biomedical subjects

J W Spicer

Publications and source records attributed to J W Spicer.

6 recordsLinked to original sources

Adjuvant and suppressive effects of Grass Conjuvac and other alginate conjugates on IgG and IgE antibody responses in mice.

BALB/c mice were immunized with grass pollen extract (GPE), GPE conjugated to sodium alginate (Conjuvac) or GPE absorbed to aluminium hydroxide gel (alum). Conjuvac was a more potent immunogen than the other two preparations of GPE when anti-GPE IgG antibody levels were compared. In contrast, the highest IgE antibody titres in the Conjuvac treated mice, were some sixteen-fold lower than the highest titres in the mice immunized with GPE in alum. The suppressive effects of Conjuvac on IgE antibody titres were also studied. Mice were immunized with 1 microgram dinitrophenyl (DNP)-GPE in alum and the anti-DNP and anti-GPE IgE antibody titres determined. After 4 and 5 weeks, the mice were injected with GPE or Conjuvac. The Conjuvac and the GPE failed to reduce the ongoing primary anti-GPE IgE responses but both suppressed the secondary responses by up to eight-fold. The suppression was not dose-related however. The ongoing primary and secondary anti-DNP IgE titres were suppressed in a dose-related manner by up to sixty-four fold by Conjuvac but GPE treatment was much less suppressive. We went on to investigate the suppressive properties of DNR-alginate (DNP-alg) conjugates. In these experiments mice were immunized with 1 microgram DNP-ovalbumin (DNP-OA) mixed with alum. After 4 and 5 weeks, the mice were injected with a dose of 6--600 micrograms DNP-alg with an average hapten density of 2 or 10 per alginate molecule. After a further 8 weeks a second injection of 1 microgram DNP-OA was given. All dose levels of both DNP-alg conjugates suppressed the continuing primary as well as the secondary anti-DNP IgE responses. It is concluded that alginate has properties similar to those of known T-cell adjuvants and that Conjuvac may prove useful in the immunotherapy of atopic allergy.

Adjuvants, Immunologic↗

Relapse by alcohol abusers.

During the first year after treatment, 44% of a sample of alcohol abusers reported relapse to alcohol use. Relapse rate increased to a peak at 6 months after treatment and then declined. Depressed or anxious mood was the reason most frequently given (31%) for relapse. Of subjects who relapsed, almost half (42%) reported a subsequent return to abstinence which was then maintained for the remainder of the followup period. Of these subjects, half (51%) reported the duration of the drinking period to be less than 2 weeks. Of subjects showing a daily drinking pattern prior to treatment, 20% showed a daily drinking pattern after relapse, 46% showed bouts of drinking and abstinence, and 33% showed abstinence with no further drinking. Of subjects showing bouts of drinking prior to treatment, none showed a daily drinking pattern after relapse, 44% showed bouts of drinking and abstinence, and 56% showed abstinence with no further drinking. There was no significant effect of sex or age on relapse rate, time to relapse, or reasons for relapse.

Adolescent↗